https://www.selleckchem.com/pr....oducts/sovleplenib-h
Interestingly, we observed a steep decrease of omissions in MA patients to control-group level post treatment. On the other hand, MA patients discounted delayed rewards significantly stronger than controls, indicating a more impulsive choice behavior both before and after treatment. The results should be interpreted with care because of the small sample and short follow-up period. Our data support earlier findings on partial recovery of cognitive deficits in MA patients. They also strengthen the indication for recently reco
Beğen
Yorum Yap
Paylaş
